Serge H. Boyer - Concepedia

Author

Serge H. Boyer

Mapp Biopharmaceutical (United States)

Also Known As

Boyer, S.H., Boyer, Serge H., S BOYER, S. H. BOYER, Scott C. Boyer, Serge Boyer, Serge H Boyer, Serge H. Boyer

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Mapp Biopharmaceutical (United States)Torrey Pines Institute For Molecular Studies Yale University Columbia University Molsoft (United States)

About

Serge H. Boyer is an author at Mapp Biopharmaceutical (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.1K
2	Biochemistry	9	9	1K
3	Natural Sciences	6	6	326
4	Engineering	3	3	111
5	Health Sciences	2	2	650

Serge H. Boyer

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases Scott J. Hecker, K. Raja Reddy, Maxim Totrov, Journal of Medicinal Chemistry Klebsiella PneumoniaePharmacotherapyAntimicrobial ChemotherapyPharmaceutical ChemistryDrug Resistance	2015	388
Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index Mark D. Erion, Edward E. Cable, Bruce R. Ito, Proceedings of the National Academy of Sciences PharmacotherapyFatty Liver DiseaseMetabolic SyndromeMedicinal ChemistryBone Turnover	2007	262
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya, Journal of Medicinal Chemistry	2020	200
Design, Synthesis, and Characterization of a Series of Cytochrome P<sub>450</sub>3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver<sup>§</sup> Mark D. Erion, K. Raja Reddy, Serge H. Boyer, Journal of the American Chemical Society	2004	157
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis Jorge Gomez‐Galeno, Qun Dang, Thanh H. Nguyen, ACS Medicinal Chemistry Letters Chemical BiologyInsulin SignalingMolecular PharmacologyAmp-activated Protein KinaseMetabolic Signaling	2010	91
Pradefovir: A Prodrug That Targets Adefovir to the Liver for the Treatment of Hepatitis B K. Raja Reddy, Michael C. Matelich, Bheemarao G. Ugarkar, Journal of Medicinal Chemistry Pharmaceutical ScienceImmunologyHepatitis BPharmacotherapyAntiviral Drug	2008	73
A Convergent Total Synthesis of Calicheamicin γ Stephen A. Hitchcock, Serge H. Boyer, Margaret Y. Chu‐Moyer, Angewandte Chemie International Edition in English	1994	70
Studies Related to the Carbohydrate Sectors of Esperamicin and Calicheamicin: Definition of the Stability Limits of the Esperamicin Domain and Fashioning of a Glycosyl Donor from the Calicheamicin Domain Randall L. Halcomb, Serge H. Boyer, Mark D. Wittman, Journal of the American Chemical Society Pharmaceutical ScienceBioorganic ChemistryGlycobiologyAltmetric Attention ScorePeptide Science	1995	64
Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs Serge H. Boyer, Hongjian Jiang, Jason Jacintho, Journal of Medicinal Chemistry	2008	64
A Remarkable Glycosidation Reaction: The Total Synthesis of Calicheamicin .gamma.1I Stephen A. Hitchcock, Margaret Y. Chu‐Moyer, Serge H. Boyer, Journal of the American Chemical Society BiosynthesisBioorganic ChemistryEngineeringBiochemistryGlycosylation	1995	59

Page 1